Impact of COVID-19 on gynaecological patient care: results of patient’s survey with 327 patients von Recker, F., Dohmen, S., Egger, E. K., Stope, M. B., Dimitrova, D., Könsgen, D., Ritter, M., Sehouli, J., Bondio, M. Gadebusch, Mustea, A.

Volltext

Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients von Oskay-Özcelik, G, Lehmacher, W, Könsgen, D, Christ, H, Kaufmann, M, Lichtenegger, W, Bamberg, M, Wallwiener, D, Overkamp, F, Diedrich, K, von Minckwitz, G, Höffken, K, Seeber, S, Mirz, R, Sehouli, J

Volltext

Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer von Mustea, A., Pirvulescu, C., Könsgen, D., Braicu, E.I., Yuan, S., Sun, P., Lichtenegger, W., Sehouli, J.

Volltext

An estrogen receptor α‐dependent regulation of estrogen receptor–related receptor α in the proliferation of endometrial carcinoma cells von SUN, P.‐M., GAO, M., WEI, L.‐H., MUSTEA, A., WANG, J.‐L., KÖNSGEN, D., LICHTENEGGER, W., SEHOULI, J.

Volltext

000140 CAN A BIWEEKLY SCHEDULE REDUCE THE TOXICITY OF CAELYX? A PHASE-II STUDY OF HEAVILY PRETREATED PATIENTS WITH RECURRENT OVARIAN CANCER von Oskay-Özcelik, G., Sehouli, J., Hindenburg, H. J., Klare, P., Könsgen, D., Mustea, A., Heinrich, G., Camara, O., Lichtenegger, W.

Volltext

Induction and secretion of pro-oncogenic heat shock protein 27 in ovarian cancer cells von Weiss, M, Stope, MB, Klinkmann, G, Könsgen, D, Brucker, S, Wallwiener, D, Burchardt, M, Mustea, A

Volltext

Analyse der biologischen Wirkung von kaltem physikalischem Plasma auf gynäkologische Tumorzellen – Eine innovative Therapiemethode für die gynäkologische Onkologie von Stope, M, Benouahi, R, Grüter, T, Pfister, F, Sander, C, Egger, E, Könsgen, D, Keyver-Paik, MD, Mustea, A

Volltext

Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells von PENGMING SUN, SEHOULI, Jalid, DENKERT, Carsten, MUSTEA, Alexander, KÖNSGEN, Dominique, KOCH, Ines, LIHUI WEI, LICHTENEGGER, Werner

Volltext

Management des Ovarialkarzinoms im Jahr 2010 - Ergebnisse einer Umfrage an 100 Patientinnen von Sehouli, J., Könsgen, D., Steinmüller, K., Lichtenegger, W.

Volltext

Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients von Gericke, Beate, Raila, Jens, Sehouli, Jalid, Haebel, Sophie, Könsgen, Dominique, Mustea, Alexander, Schweigert, Florian J

Volltext

An estrogen receptor ?-dependent regulation of estrogen receptor?related receptor ? in the proliferation of endometrial carcinoma cells von SUN, P.-M., GAO, M., WEI, L.-H., MUSTEA, A., WANG, J.-L., KÖNSGEN, D., LICHTENEGGER, W., SEHOULI, J.

Volltext

Expression of IL-10 in Patients with Ovarian Carcinoma von MUSTEA, Alexander, KÖNSGEN, Dominique, BRAICU, Elena Ioana, PIRVULESCU, Cristina, PENGMING SUN, SOFRONI, Dumitru, LICHTENEGGER, Werner, SEHOULI, Jalid

Volltext

Lebensqualität in der gynäkologischen Onkologie -Ein Bericht mit den Ergebnissen des ASCO-Meetings 2002 von SEHOULL, J, KÖNSGEN, D, KLAPP, C, WALLE, U, KATSARES, I, OSKAY, G, MUSTEA, A, BÜHLING, K, LICHTENEGGER, W

Volltext

Epidermal growth factor receptor (EGFR) mutation incidence in Caucasian ovarian cancer patients von Mustea, A, Könsgen, D, Zeillinger, R, Castillo-Tong, D, Pirvulescu, C, Lichtenegger, W, Sehouli, J

Volltext

Dose-finding study of Topotecan (T) plus Carboplatin (C) for patients with platinum sensitive Relapsed Ovarian Cancer (ROC) von Könsgen, D, Belau, A, Klare, P, Camara, O, Sommer, H, Lichtenegger, W, Sehouli, J

Volltext

Cervical Cancer and -463G/A Polymorphism of MPO Gene von Mustea, A, Könsgen, D, Castillo-Tong, D, Braicu, I, Zeillinger, R, Sehouli, J, Lichtenegger, W

Volltext

Role of the novel PAI-1 RNA Binding Protein in Epithelial Ovarian Cancer von Könsgen, D, Mustea, A, Dahl, E, Klaman, I, Lichtenegger, W, Sehouli, J

Volltext

An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma von Meinhold-Heerlein, I, Bauerschlag, D, Bräutigam, K, Sehouli, J, Stickeler, E, Könsgen, D, Hilpert, F, von Kaisenberg, C, Pfisterer, J, Bauknecht, T, Schollmeyer, T, Jonat, W, Arnold, N

Volltext

EXPRESSION PATTERN OF HUMAN ESTROGEN RECEPTOR- RELATED RECEPTOR – ALFA-BETA, A SUB- FAMILY OF ORPHAN NUCLEAR RECEPTORS, AND THE ESTROGEN RECEPTOR ON HUMAN OVARIAN CANCER CELL LINES... von Sun, P. M, Sehouli, J., Wei, L. H, Denkert, C., Mustea, A., Corch, I., Litchnegger, W., Konsgen, D.

Volltext

Transthyretin – Microheterogeneity of a nutritional marker in ovarian cancer research von Gericke, B, Raila, J, Haebel, S, Sehouli, J, Könsgen, D, Mustea, A, Schweigert, FJ

Volltext